These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31326268)

  • 1. Vascular Complications and Procedures Following Transcatheter Aortic Valve Implantation.
    Raju S; Eisenberg N; Montbriand J; Cusimano RJ; Feindel C; Ouzounian M; Horlick E; Osten M; Tsang W; Roche-Nagle G
    Eur J Vasc Endovasc Surg; 2019 Sep; 58(3):437-444. PubMed ID: 31326268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in vascular complications and associated treatment strategies following transfemoral transcatheter aortic valve replacement.
    Ullery BW; Jin R; Kirker EB; Hayes G; Siwek L; Brevig J; Hodson RW; Spinelli KJ
    J Vasc Surg; 2020 Oct; 72(4):1313-1324.e5. PubMed ID: 32169358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed Tomographic Angiography-Derived Risk Factors for Vascular Complications in Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
    Urbach J; Hou CR; Lesser JR; Stanberry LI; Garberich RF; Caye D; Sorajja P; Gössl M
    Am J Cardiol; 2019 Jul; 124(1):98-104. PubMed ID: 31029410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Predictors, and Impact of Vascular Complications After Transfemoral Transcatheter Aortic Valve Implantation With the SAPIEN 3 Prosthesis.
    van Kesteren F; van Mourik MS; Vendrik J; Wiegerinck EMA; Henriques JPS; Koch KT; Wykrzykowska JJ; de Winter RJ; Piek JJ; van Lienden KP; Reekers JA; Vis MM; Planken RN; Baan J
    Am J Cardiol; 2018 May; 121(10):1231-1238. PubMed ID: 29703437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Prognosis and Predictors of Major Vascular Complications and Percutaneous Closure Device Failure Following Contemporary Percutaneous Transfemoral Transcatheter Aortic Valve Replacement.
    Batchelor W; Patel K; Hurt J; Totten J; Burroughs P; Smith G; Cuervo M; Davis L; Damluji AA; Epps K; Sherwood M; Barnett S; Geloo N; Yazdani S; Sarin E; Ryan L; Noel T
    Cardiovasc Revasc Med; 2020 Sep; 21(9):1065-1073. PubMed ID: 31974033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized Measurement of Femoral Artery Depth by Computed Tomography to Predict Vascular Complications After Transcatheter Aortic Valve Implantation.
    Durand E; Penso M; Hemery T; Levesque T; Moles G; Tron C; Bouhzam N; Bettinger N; Wong S; Dacher JN; Eltchaninoff H
    Am J Cardiol; 2021 Apr; 145():119-127. PubMed ID: 33460601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of vascular complications following transcatheter aortic valve implantation.
    Perrin N; Ellenberger C; Licker M; Hachulla AL; Cikirikcioglu M; Frei A; Roffi M; Noble S
    Arch Cardiovasc Dis; 2015 Oct; 108(10):491-501. PubMed ID: 26073229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular complications after transcatheter transfemoral aortic valve implantation: Modified sheath-to-femoral artery ratio as a new predictor.
    Çakal S; Çakal B; Karaca O; Güler Y; Özcan ÖU; Güneş HM; Kızılırmak Yılmaz F; Yıldırım A; Boztosun B
    Anatol J Cardiol; 2022 Jan; 26(1):49-56. PubMed ID: 35191386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictors, impact, and treatment of vascular complications after transcatheter aortic valve implantation in a modern prospective cohort under real conditions.
    Langouet Q; Martinez R; Saint-Etienne C; Behlaj Soulami R; Harmouche M; Aupart M; Le Breton H; Verhoye JP; Bourguignon T
    J Vasc Surg; 2020 Dec; 72(6):2120-2129.e2. PubMed ID: 32276023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implantation Karlsruhe (TAVIK) registry.
    Conzelmann LO; Würth A; Schymik G; Schröfel H; Anusic T; Temme S; Tzamalis P; Gerhardus J; Mukherjee C; Gonska BD; Schmitt C; Mehlhorn U
    Eur J Cardiothorac Surg; 2018 Oct; 54(4):752-761. PubMed ID: 29617804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Complications and Bleeding After Transfemoral Transcatheter Aortic Valve Implantation Performed Through Open Surgical Access.
    Leclercq F; Akodad M; Macia JC; Gandet T; Lattuca B; Schmutz L; Gervasoni R; Nogue E; Nagot N; Levy G; Maupas E; Robert G; Targosz F; Vernhet H; Cayla G; Albat B
    Am J Cardiol; 2015 Nov; 116(9):1399-404. PubMed ID: 26414600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Iliac Morphology Score Predicts Procedural Mortality and Major Vascular Complications in Transfemoral Aortic Valve Replacement.
    Blakeslee-Carter J; Dexter D; Mahoney P; Ahanchi S; Steerman S; Larion S; Cain B; Panneton JM
    Ann Vasc Surg; 2018 Jan; 46():208-217. PubMed ID: 28689947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation.
    Seidler T; Hünlich M; Puls M; Hasenfuß G; Jacobshagen C
    Clin Res Cardiol; 2017 Mar; 106(3):183-191. PubMed ID: 27687044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions.
    Steinvil A; Leshem-Rubinow E; Halkin A; Abramowitz Y; Ben-Assa E; Shacham Y; Bar-Dayan A; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2015 Jan; 115(1):100-6. PubMed ID: 25456874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends over the past 4 years in population characteristics, 30-day outcomes and 1-year survival in patients treated with transcatheter aortic valve implantation.
    Avinée G; Durand E; Elhatimi S; Bauer F; Glinel B; Dacher JN; Cellier G; Viart G; Tron C; Godin M; Litzler PY; Cribier A; Eltchaninoff H
    Arch Cardiovasc Dis; 2016; 109(8-9):457-64. PubMed ID: 27342810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iliofemoral artery lumen volume assessment with three dimensional multi-detector computed tomography and vascular complication risk in transfemoral transcatheter aortic valve replacement.
    Hammer Y; Landes U; Zusman O; Kornowski R; Witberg G; Orvin K; Levi A; Codner P; Vaknin-Assa H; Nassar M; Shafir G; Assali A; Hamdan A
    J Cardiovasc Comput Tomogr; 2019; 13(1):68-74. PubMed ID: 30340961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of MANTA vs ProGlide Vascular Closure Device and 30-Day Outcomes in Transfemoral Transcatheter Aortic Valve Implantation.
    Eftychiou C; Eteocleous N; Mitsis A; Zittis I; Papadopoulos K; Petrou A; Adamou M; Kounnos C; Bekos C; Avraamides P
    Tex Heart Inst J; 2022 Sep; 49(5):. PubMed ID: 36269884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus is not associated with worse vascular outcome following percutaneous transfemoral transcatheter aortic valve implantation.
    Lareyre F; Mialhe C; Bourlon F; Habib Y; Dommerc C; Raffort J
    Acta Cardiol; 2019 Dec; 74(6):480-486. PubMed ID: 30642229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.